Kyle Fischer, PharmD, BCCP, MBA

10.2K posts

Kyle Fischer, PharmD, BCCP, MBA banner
Kyle Fischer, PharmD, BCCP, MBA

Kyle Fischer, PharmD, BCCP, MBA

@Kfischer_10

🫀 trained @dukehealth | IM @utswmedcenter | Obsessed w/ @texasfootball, Cardiac CritCare, HF, ACS, Apolipoproteins, Preventative cardiology -views my own

Texas, USA Katılım Ağustos 2011
1.4K Takip Edilen2.6K Takipçiler
Sabitlenmiş Tweet
Kyle Fischer, PharmD, BCCP, MBA
Had a blast recording with @SpencerCarter55 and @Corconsultrx - be sure to check out our discussion over HFpEF 🤩🫀 #medtwitter #twitteRx @UTSWNews @UTSWedu @UTSWCardfellow @utswheart
CorConsult Rx@Corconsultrx

On episode 162, we were joined by some awesome guests @spencercarter55 and @Kfischer_10 , to discuss preserved ejection fraction heart failure. You do not want to miss this episode! corconsultrxpodcast.libsyn.com/new-data-in-hf…

English
0
2
18
0
Kyle Fischer, PharmD, BCCP, MBA retweetledi
Kyle Fischer, PharmD, BCCP, MBA retweetledi
JACC Journals
JACC Journals@JACCJournals·
In #ACS patients after #PCI, meta-analysis 📊 shows P2Y12 inhibitor 💊 monotherapy after short #DAPT lowers net adverse clinical events & bleeding 🩸 vs aspirin 💊, which had neutral results ➡️ better safety profile ✅ jacc.org/doi/10.1016/j.… #JACCINT #cvACS #P2Y12i
JACC Journals tweet mediaJACC Journals tweet mediaJACC Journals tweet mediaJACC Journals tweet media
English
0
22
53
5.6K
Kyle Fischer, PharmD, BCCP, MBA retweetledi
ACCP Cardiology PRN
ACCP Cardiology PRN@accpcardprn·
Check out this incredible #TeachingTuesday post on LV thrombus by Zaynab Omisade and her mentor @Kfischer_10! Do you initiate loading doses for DOACs in your practice?
ACCP Cardiology PRN tweet mediaACCP Cardiology PRN tweet mediaACCP Cardiology PRN tweet mediaACCP Cardiology PRN tweet media
English
1
9
44
4.9K
Kyle Fischer, PharmD, BCCP, MBA retweetledi
Robert Mentz, MD
Robert Mentz, MD@robmentz·
Mechanistic Differences between Torsemide and Furosemide Prospective data debunks classic teachings 🔵No meaningful PK/PD advantages for T 🔵Kidney bioavailability less w T 🔵Ratio T:F was 4:1 (not 2:1!) 🔵T w ⬆️neurohormonal activ & kidney dysfunction journals.lww.com/jasn/abstract/…
Robert Mentz, MD tweet mediaRobert Mentz, MD tweet media
English
10
79
230
35.2K
Kyle Fischer, PharmD, BCCP, MBA retweetledi
Pablo Corral MD
Pablo Corral MD@drpablocorral·
👉ApoB triumphs once more over LDL-C and non-HDL-C in risk prediction: ready for guidelines? ☝️ In conclusion, the era of focusing solely on LDL-C for assessing cholesterol-driven risk is coming to an end. ☝️These findings advocate for the integration of apoB as a central component in ASCVD risk prediction within future guidelines for dyslipidaemia management and cardiovascular disease prevention Open Access 🔓 academic.oup.com/eurheartj/adva… @society_eas
Pablo Corral MD tweet media
English
16
110
365
61K
Kyle Fischer, PharmD, BCCP, MBA retweetledi
JACC Journals
JACC Journals@JACCJournals·
Despite overwhelming evidence, <50% of statin-eligible patients receive treatment. This work evaluates the efficacy of a consumer-facing web app for non-prescription statin selection. bit.ly/3Kbi8mX #JACC #CardioTwitter #Cardiology
JACC Journals tweet media
English
1
20
75
15.5K
Kyle Fischer, PharmD, BCCP, MBA retweetledi
Hugo Chrost
Hugo Chrost@chrost_hugo·
Management of Status Epilepticus. Any comments? Credits: @Kfischer_10 #MedTwitter
Hugo Chrost tweet media
English
0
117
319
16.8K
Kyle Fischer, PharmD, BCCP, MBA retweetledi
JAHA
JAHA@JAHA_AHA·
Should ApoB be applied widely in clinical care? Multiple expert groups have confirmed its accuracy, precision, and selectivity surpass that of LDL-C and non-HDL-C. The future looks bright w/ mass spec methods enhancing standardization. #AHAJournals #Review ahajrnls.org/3DSrYqS
English
2
16
62
47.1K
Kyle Fischer, PharmD, BCCP, MBA retweetledi
JACC Journals
JACC Journals@JACCJournals·
🆕 ACC Expert Consensus Decision Pathway on the Management of #HFpEF addresses diagnostic challenges tied to EF threshold, correct terminology, gender/sex differences, & the lack of a single test that definitively establishes Dx. bit.ly/41phjhE #JACC #CardioTwitter
JACC Journals tweet media
English
1
75
136
61.3K
Kyle Fischer, PharmD, BCCP, MBA retweetledi
ACC Media Center
ACC Media Center@ACCmediacenter·
Commenting on COORDINATE-Diabetes, Dr. Kristen Campbell says the “multifaceted design is notably simple and that’s particular strength to this trial,” adding “These results can be extrapolated to different disease states.” #ACC23/#WCCardio
ACC Media Center tweet media
English
0
2
11
4K